DK1246610T3 - Straksgranulater og fremgangsmåde til deres fremstilling - Google Patents

Straksgranulater og fremgangsmåde til deres fremstilling

Info

Publication number
DK1246610T3
DK1246610T3 DK01905653T DK01905653T DK1246610T3 DK 1246610 T3 DK1246610 T3 DK 1246610T3 DK 01905653 T DK01905653 T DK 01905653T DK 01905653 T DK01905653 T DK 01905653T DK 1246610 T3 DK1246610 T3 DK 1246610T3
Authority
DK
Denmark
Prior art keywords
active substance
coated
soluble
carrier material
weight
Prior art date
Application number
DK01905653T
Other languages
English (en)
Inventor
Gerhard Gergely
Irmgard Gergely
Original Assignee
Gergely Dr & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gergely Dr & Co filed Critical Gergely Dr & Co
Application granted granted Critical
Publication of DK1246610T3 publication Critical patent/DK1246610T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01905653T 2000-01-10 2001-01-08 Straksgranulater og fremgangsmåde til deres fremstilling DK1246610T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH332000 2000-01-10
EP00101924A EP1116485A3 (de) 2000-01-10 2000-02-01 Instant-Granulat und Verfahren zu seiner Herstellung
PCT/EP2001/000096 WO2001051026A2 (en) 2000-01-10 2001-01-08 Instant granules and process for their formulation

Publications (1)

Publication Number Publication Date
DK1246610T3 true DK1246610T3 (da) 2005-08-15

Family

ID=4253424

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01905653T DK1246610T3 (da) 2000-01-10 2001-01-08 Straksgranulater og fremgangsmåde til deres fremstilling

Country Status (13)

Country Link
US (1) US6645529B2 (da)
EP (2) EP1116485A3 (da)
JP (1) JP4959895B2 (da)
CN (1) CN1179720C (da)
AT (1) ATE292958T1 (da)
AU (1) AU2001233687A1 (da)
CA (1) CA2396223C (da)
DE (1) DE60110034T2 (da)
DK (1) DK1246610T3 (da)
ES (1) ES2240405T3 (da)
NO (1) NO328899B1 (da)
RU (1) RU2262336C2 (da)
WO (1) WO2001051026A2 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
SI1031347T1 (en) 1999-01-27 2002-10-31 Idea Ag Transnasal transport/immunisation with highly adaptable carriers
EP1031346B1 (en) 1999-01-27 2002-05-02 Idea Ag Noninvasive vaccination through the skin
WO2001001962A1 (en) * 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
JP3211824B1 (ja) * 2000-10-26 2001-09-25 味の素株式会社 分岐鎖アミノ酸含有医薬用顆粒製剤とその製造方法
NZ533808A (en) * 2001-12-21 2005-03-24 Biopartners Gmbh Ribavirin granulate for producing coated tablets
JP3368898B1 (ja) * 2002-01-24 2003-01-20 味の素株式会社 分岐鎖アミノ酸含有顆粒の製造方法
WO2004017947A1 (en) * 2002-08-21 2004-03-04 Phoqus Pharmaceuticals Limited Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
US9247765B2 (en) 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
US7799273B2 (en) 2004-05-06 2010-09-21 Smp Logic Systems Llc Manufacturing execution system for validation, quality and risk assessment and monitoring of pharmaceutical manufacturing processes
US7444197B2 (en) 2004-05-06 2008-10-28 Smp Logic Systems Llc Methods, systems, and software program for validation and monitoring of pharmaceutical manufacturing processes
WO2006050926A2 (en) * 2004-11-12 2006-05-18 Idea Ag Extended surface aggregates in the treatment of skin conditions
UA95093C2 (uk) 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
US9974319B2 (en) 2006-03-29 2018-05-22 Purac Biochem B.V. Partially neutralized polycarboxylic acids for acid-sanding
TWI503128B (zh) 2007-07-31 2015-10-11 Ajinomoto Kk A granule preparation containing an amino acid with excellent taste
WO2011043647A1 (en) * 2009-10-09 2011-04-14 N.V. Nutricia Amino acid composition with improved dispersibility
KR101125453B1 (ko) * 2010-07-29 2012-03-27 주식회사 대웅제약 엘-트립토판의 가용화 조성물 및 이를 이용한 제제
CN105076729A (zh) * 2015-09-16 2015-11-25 中粮饲料有限公司 一种饲料添加剂微胶囊及其制备方法
CN106806345B (zh) * 2015-11-27 2020-10-13 北京科信必成医药科技发展有限公司 一种利巴韦林掩味颗粒及其制备方法
CN113974171A (zh) * 2021-11-08 2022-01-28 北京素维生物科技有限公司 一种微水快溶组合物、微水快溶食品或药品以及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
DE2618100A1 (de) * 1976-04-26 1977-11-03 Fresenius Chem Pharm Ind Geschmacksneutrales, l-aminosaeuren enthaltendes granulat
IT1212792B (it) * 1983-11-30 1989-11-30 Egidio Aldo Moja Supplemento dietetico e alimento preconfezionato che lo contiene procedimento di preparazione e metodo di somministrazione
DE3440288A1 (de) * 1984-11-05 1986-05-07 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische zubereitung mit einem gehalt an mindestens einer schleimhautreizenden substanz oder dergleichen, insbesondere profen, sowie verfahren zu ihrer herstellung
EP0241469B1 (de) * 1984-12-14 1991-10-23 Gergely, Gerhard, Dr. Teilchen aus einer hydrophoben oder schwerlöslichen substanz und verfahren zu ihrer hydrophilisierung
FR2682874B1 (fr) * 1991-10-24 1993-12-10 Rinrone Ets Procede pour la preparation d'un extrait de principes actifs sous forme seche adsorbable et microgranules adsorbables ainsi obtenus.
US5455049A (en) * 1995-01-04 1995-10-03 Ascent Pharmaceuticals, Inc. Terfenadine oral powder
DE19733505A1 (de) * 1997-08-01 1999-02-04 Knoll Ag Schnell wirksames Analgeticum
US6096343A (en) * 1997-10-27 2000-08-01 Gerhard Gergely Instant calcium/soybean granules, their use and process for their preparation

Also Published As

Publication number Publication date
WO2001051026A3 (en) 2002-03-21
NO20022875D0 (no) 2002-06-17
AU2001233687A1 (en) 2001-07-24
US6645529B2 (en) 2003-11-11
JP2003519649A (ja) 2003-06-24
CN1394136A (zh) 2003-01-29
EP1246610A2 (en) 2002-10-09
EP1246610B1 (en) 2005-04-13
NO20022875L (no) 2002-08-06
RU2002121486A (ru) 2004-03-20
DE60110034T2 (de) 2006-03-02
EP1116485A3 (de) 2002-01-16
EP1116485A2 (de) 2001-07-18
ATE292958T1 (de) 2005-04-15
WO2001051026A2 (en) 2001-07-19
JP4959895B2 (ja) 2012-06-27
NO328899B1 (no) 2010-06-07
DE60110034D1 (de) 2005-05-19
RU2262336C2 (ru) 2005-10-20
CA2396223A1 (en) 2001-07-19
US20020168386A1 (en) 2002-11-14
CN1179720C (zh) 2004-12-15
CA2396223C (en) 2009-06-02
ES2240405T3 (es) 2005-10-16

Similar Documents

Publication Publication Date Title
DK1246610T3 (da) Straksgranulater og fremgangsmåde til deres fremstilling
ATE486585T1 (de) Mehrstufiges orales arzneimittelsystem mit kontrollierter freisetzung
IE901256L (en) Pesticides
IS6348A (is) (1a,3a,5a)(3-amínómetýl bísýkló[3.2.0]hept-3-ýl)-ediksýra, lyfjasamsetningar og notkun efnasambandsins til framleiðslu á lyfjum
DK0670160T3 (da) Granulært præparat eller tablet omfattende et brusemiddel og et aktivt farmaceutisk stof samt fremgangsmåde til dets fremst
ATE240719T1 (de) Pharmazeutische tablette mit verzögerter freisetzung, enthaltend eine matrix aus quervernetzter amylose und hydroxypropyl methylzellulose
DK0560092T3 (da) Tabletter, granulater og pellets med højt indholdaf aktivstoffer til højkoncentrerede, faste administreringsformer
ES2075061T3 (es) Composicion farmaceutica a base de una resina de intercambio ionico.
HUP0004924A2 (hu) Ciklodextrineket tartalmazó gyógyászati készítmények
AR024653A1 (es) Procedimiento para la obtencion de preparados farmaceuticos solidos de disgregacion rapida
DK1077680T3 (da) Fremgangsmåde til fremstilling af en med bånd forsynet aktivt-stof-doseringsform til prolongeret release
FI892797A0 (fi) Granulerad produkt pao basis av fruktos och foerfarande foer dess framstaellning.
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
ATE124257T1 (de) Granulate mit hohem ibuprofengehalt.
PT1195160E (pt) Composições farmacêuticas de trimetazidina de libertação sustentada e método para a sua preparação
BG108870A (en) Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
AU5523599A (en) Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications
WO2003063824A3 (en) Pharmaceutical composition
AU2001258662A1 (en) Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds
DK1200070T3 (da) Ambroxolholdig sugetablet
WO2002024164A3 (fr) Procede de granulation par extrusion basse pression
NO993841L (no) Blandinger og anordninger for redusering av virkningene av inflammasjon
JPS5282715A (en) Long acting drug composition
CA2532714A1 (en) Oral sustained-release tablet comprising 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide
AU2944100A (en) Gene therapeutics